EUVIMEDEUVIMED entdecken
Crossref

EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway

Zumu Xiao, Shengxuan Huang, Wenjin Qiu, Mengru Pang, Xi Zeng, Xu Xu, Yushi Yang, Binglin Yang, Liangzhao Chu

Brain Research · 2024

DOI: 10.1016/j.brainres.2024.148796 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Zumu Xiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian, China; Department of Neurosurgery, the A…. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Glioma. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Natural Science Foundation of Fujian Province, Guizhou Medical University, Department of Education of Guizhou Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Eph receptors are the largest subfamily of receptor tyrosine kinases, and they have been shown to play a crucial role in glioma. The EphB3 receptor is a member of this family, and its effect on the invasion, migration and proliferation of glioma cells was examined in this study. It was found that the expression of EphB3 was decreased in glioma specimens with increasing tumor grade. Additionally, the U87MG and U251 cell lines showed low levels of EphB3 expression. This finding was consistent with the negative correlation between EphB3 expression in glioma tissues and tumor grade. Depletion of EphB3 gene in U87MG and U251 cell lines resulted in a substantial enhancement of their invasion, migration, and proliferation capacities in vitro. Furthermore, the knockdown of EphB3 led to an upregulation of EGFR, p-PI3K, and p-AKT protein levels. On the other hand, EphB3 overexpression reduced the invasiveness, proliferative capacity and migration rate of U87MG and U251 cells, and downregulated EGFR, p-PI3K and p-AKT. These findings indicate that EphB3 functions as a tumor suppressor in glioma, and its downregulation enhances the malignant potential of glioma cells by activating the EGFR-PI3K/AKT pathway. Thus, EphB3 is a promising diagnostic marker for glioma, and the EphB3-EGFR-PI3K / AKT axis deserves further investigation as a potential therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktGliomaHumansPhosphatidylinositol 3-KinasesReceptor, EphB3Cell ProliferationSignal TransductionErbB ReceptorsCell Line, TumorCell MovementNeoplasm Invasiveness

Stichwörter der Autor:innen

EphB3 receptorGliomaInvasionMigrationPI3K/AKTProliferation

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesReceptor, EphB3ErbB ReceptorsEGFR protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian, China; Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, Ch…
  • Department of Neurosurgery, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian, China.
  • Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Burn and Plastic Surgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China.
  • Department of Neurosurgery, the Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China. Electronic address: 903026198@qq.com.
  • Department of Breast, Sanming First Hospital Affiliated to Fujian Medical University, Sanming, Fujian, China. Electronic address: yangbinglin2005@126.com.

Förderung

  • Natural Science Foundation of Fujian Province
  • Guizhou Medical University
  • Department of Education of Guizhou Province
  • Izumi Science and Technology Foundation
  • Science and Technology Program of Guizhou Province

Zitieren

APA

Xiao, Z., Huang, S., Qiu, W., Pang, M., Zeng, X., Xu, X., Yang, Y., Yang, B., & Chu, L. (2024). EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway. Brain Research. https://doi.org/10.1016/j.brainres.2024.148796

Vancouver

Xiao Z, Huang S, Qiu W, Pang M, Zeng X, Xu X, et al. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway. Brain Research. 2024. doi:10.1016/j.brainres.2024.148796

BibTeX
@article{Xiao2024,
  author = {Xiao, Zumu and Huang, Shengxuan and Qiu, Wenjin and Pang, Mengru and Zeng, Xi and Xu, Xu and Yang, Yushi and Yang, Binglin and Chu, Liangzhao},
  title = {EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway},
  journal = {Brain Research},
  year = {2024},
  doi = {10.1016/j.brainres.2024.148796}
}
Kostenlos starten →